Symbol="IBRX"
AssetType="Common Stock"
Name="Immunitybio Inc"
Description="ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy. "
CIK="1326110"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="3530 JOHN HOPKINS COURT, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1225118000"
EBITDA="-347424992"
PERatio="None"
PEGRatio="None"
BookValue="-1.213"
DividendPerShare="0"
DividendYield="0"
EPS="-1.02"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-625.04"
ReturnOnAssetsTTM="-0.625"
ReturnOnEquityTTM="0"
RevenueTTM="586000"
GrossProfitTTM="240000"
DilutedEPSTTM="-1.02"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="24.71"
AnalystTargetPrice="4.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4822.33"
PriceToBookRatio="-"
EVToRevenue="5498.73"
EVToEBITDA="-8.89"
Beta="-0.264"
num_52WeekHigh="7.8"
num_52WeekLow="1.21"
num_50DayMovingAverage="2.871"
num_200DayMovingAverage="3.739"
SharesOutstanding="435985000"
DividendDate="None"
ExDividendDate="None"
symbol="IBRX"
open="2.95"
high="2.95"
low="2.75"
price="2.81"
volume="2062683.00"
latest_trading_day="2023-07-21"
previous_close="2.89"
change="-0.08"
change_percent="-2.7682%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="4718323"
Change_recent_avg="0.02"
Delta_recent_avg="0.33"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="-0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0043.jpeg"
image_negative_thumbnail_id_2="138"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0038.jpeg"
image_neutral_thumbnail_id_1="543"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="1006"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_positive_thumbnail_id_2="1009"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
